Huicochea CS, González BP, Tovar CIL, Olarte CMÁ, Vázquez LJ

Language: Spanish
References: 22
Page: 117-126
PDF size: 764.90 Kb.

ABSTRACT

Introduction: Breast cancer is one of the main causes of mortality in our country. The use of mastography as screening method has decreased mortality from breast cancer, being the study of election in high-risk women; magnetic resonance and ultrasound are useful complementary methods.
Diagnosis: Mastography is also the method of election for diagnosis. For staging and evaluation of the response to treatment, breast magnetic resonance, nuclear scan and gammagraphy and positron emission tomography CT studies play a primary role. This article highlights main breast cancer aspects and the role of the different imaging useful methods for detection, diagnosis, staging, and evaluation of the response to the breast cancer treatment.

REFERENCES

1. Warren SL. Roentgenologic study of the breast. AJR Am J Roentgenol 1930; 24: 113-24.

2. Benson JR, Jatoi I, Keisch M, Esteva FJ, Makris A, Jordan VC. Early breast cancer. Lancet 2009 373(9673): 1463-79.

3. Kaplan RM, Porzsolt F. The natural history of breast cancer. Arch Intern Med 2008 168(21): 2302-3.

4. Aguayo-Alckaraz G, Jimenez-Perez LM, Celis-de la Rosa A, Canales-Munoz JL. Breast cancer mortality. Trend and geographical distribution, 1981-2001. Rev Med Inst Mex Seguro Soc 2008 46(4): 367-74.

5. Rodriguez CSA, Capurso GM. Epidemiology of breast cancer. Ginecol Obstet Mex 2006 74(11): 585-93.

6. Knaul FM, Nigenda G, Lozano R, Arreola-Ornelas H, Langer A, Frenk J. Breast cancer in Mexico: a pressing priority. Reprod Health Matters 2008 16(32): 113-23.

7. Couture MC, Nguyen CT, Alvarado BE, Velasquez LD, Zunzunegui MV. Inequalities in breast and cervical cancer screening among urban Mexican women. Prev Med 2008; 47(5): 471-6.

8. Brandan ME, Villaseñor Y. Detección del cáncer de mama: Estado de la mamografía en México.Rev Inst Nal Cancerol 2006; 1: 147-62.

9. NOM-041-SSA2-2002, Para la prevención, diagnóstico, tratamiento, control y vigilancia epidemiológica del cáncer de mama. Diario Oficial, 17 septiembre 2003.

10. Calderon-Garciduenas AL, Paras-Barrientos FU, Cardenas-Ibarra L, Gonzalez- Guerrero JF, Villarreal-Rios E, Staines-Boone T, et al. Risk factors of breast cancer in Mexican women. Salud Publica Mex 2000; 42(1): 26.

11. Bartella L, Smith CS, Dershaw DD, Liberman L. Imaging breast cancer. Radiol Clin North Am 2007; 45(1): 45-67.

12. Heywang-Köbrunner SH, Dershaw DD, Schreer I. Diagnostic Breast Imaging. 2nd Ed. New York, NY: Thieme; 2001.

13. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography (Cochrane Review). In: The Cochrane Library, Issue 4, 2008. Oxford: Update Software.

14. Tice JA, Kerlikowske K. Screening and Prevention of Breast Cancer in Primary Care. Prim Care 2009; 36(3): 533-58.

15. Berg WA. Tailored supplemental screening for breast cancer: what now and what next? AJR Am J Roentgenol 2009; 192(2): 390-9. Review.

16. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007; 57(2): 75-89.

17. Yang W, Dempsey PJ.Diagnostic breast ultrasound: current status and future directions. Radiol Clin North Am 2007; 45(5): 845-61.

18. Morris EA.Diagnostic breast MR imaging:current status and future directions. Radiol Clin North Am 2007; 45(5): 863-80.

19. BergWA, Birdwell R, Gombos EC. Diagnostic imaging breast. 1st. Ed. Salt Lake City, Utah: AMIRSYS; 2006.

20. D’Orsi CJ, et al. Breast Imaging Reporting and Data System (BI-RADS). 4th Ed. ACR; 2003.

21. Greene FL, Page DL, Flemig ID, et al. AJCC Cancer staging manual. 6th. Ed. New York, NY: Springer Verlag; 2002.

22. Lee JH, Rosen EL, Mankoff DA. The role of radiotracer imaging in diagnosis and management of patients with breast cancer: part 1-overview, detection and staging. J Nucl Med 2009; 50(4): 569-81.